Home>Valeant Pharmaceuticals International VRX Q4 2011 Earnings Call Transcript
Valeant Pharmaceuticals International VRX Q4 2011 Earnings Call Transcript
Earnings Call Transcripts by Morningstar Inc.
Mon, 27 Feb 2012
Good morning. My name is Matthew and I will be your conference operator today. At this time, I'd like to welcome everyone to the Valeant Pharmaceuticals Fourth Quarter 2011 Year End Conference Call. All lines have been placed on mute to prevent any
With yield spreads back to pre-crisis levels, there is less room for error in the high-yield market today, says Morningstar director of fixed-income research Eric Jacobson.
Morningstar associate director of fund analysis Miriam Sjoblom explains what drove municipal bonds' great performance in 2011 and what issues may lie ahead for muni investors.
While duration exposure remains troublesome, large-scale bank deleveraging in the last year has credit markets looking ripe for investment, says Driehaus' K.C. Nelson.